Imprimatur Capital
Overview
Imprimatur is an operational investment business active on an international basis and focussed on the commercialisation of high-growth IP backed opportunities from Universities, research institutes and other sources. The fund invests in the commercialisation of opportunities from universities, research institutes and other sources.
Investment Focus
- Innovative technology based on strong intellectual property
- Scalable business model addressing global markets
- Experienced management team
- Clear development path from seed or start-up stage through commercialization to international market traction and rapid growth
- Sustainable competitive advantages in a large growing market
Portfolio Companies
Reach Imprimatur Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Imprimatur Capital
What sectors does Imprimatur Capital invest in?
Imprimatur Capital invests in Technology, Healthcare, Software, Education, HealthTech and EdTech, and is based in London, England, United Kingdom. Imprimatur Capital is listed as a vc in the ConnectSafely investor database.
What stage does Imprimatur Capital invest at?
Imprimatur Capital backs companies at Seed and Series B, writing cheques of 100K - 400K.
Which regions does Imprimatur Capital invest in?
Imprimatur Capital invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Imprimatur Capital invested in?
Imprimatur Capital's portfolio includes Anatomy Next.
How do I contact Imprimatur Capital?
Imprimatur Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
